Tumor progression and recurrence after direct-acting antiviral therapy for hepatitis C in patients with previously treated or active hepatocellular carcinoma

被引：0
|
作者：
Wong, M. Y. W. [1 ]
Mccaughan, G. W. [1 ]
Mason, S. [1 ]
Moore, B. [1 ]
Koorey, D. J. [1 ]
Bowen, D. G. [1 ]
Strasser, S. I. [1 ]
机构：
[1] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [1] Tumour progression and recurrence after direct acting antiviral therapy for hepatitis C in patients with previously treated or active hepatocellular carcinoma
    Wong, M.
    Mccaughan, G.
    Mason, S.
    Moore, B.
    Bowen, D.
    Koorey, D.
    Strasser, S.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S418 - S418
  • [2] Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
    Lee, Chang Hun
    Kim, In Hee
    GUT AND LIVER, 2021, 15 (03) : 327 - 328
  • [3] Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C
    Ahn, Young-Hwan
    Lee, Heirim
    Kim, Do Young
    Lee, Hye Won
    Yu, Su Jong
    Cho, Young Youn
    Jang, Jeong Won
    Jang, Byoung Kuk
    Kim, Chang Wook
    Kim, Hee Yeon
    Park, Hana
    Cho, Hyo Jung
    Park, Bumhee
    Kim, Soon Sun
    Cheong, Jae Youn
    GUT AND LIVER, 2021, 15 (03) : 410 - 419
  • [4] Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C
    Virlogeux, Victor
    Pradat, Pierre
    Hartig-Lavie, Kerstin
    Bailly, Francois
    Maynard, Marianne
    Ouziel, Guillaume
    Poinsot, Domitille
    Lebosse, Fanny
    Ecochard, Marie
    Radenne, Sylvie
    Benmakhlouf, Samir
    Koffi, Joseph
    Lack, Philippe
    Scholtes, Caroline
    Uhres, Anne-Claire
    Ducerf, Christian
    Mabrut, Jean-Yves
    Rode, Agnes
    Levrero, Massimo
    Combet, Christophe
    Merle, Philippe
    Zoulim, Fabien
    LIVER INTERNATIONAL, 2017, 37 (08) : 1122 - 1127
  • [5] Hepatocellular carcinoma recurrence after curative treatments in patients with chronic hepatitis C who underwent direct-acting antiviral therapy
    Minami, Tatsuya
    Tateishi, Ryosuke
    Wake, Taijiro
    Nishibatake, Mizuki
    Nakagomi, Ryo
    Sato, Masaya
    Uchino, Koji
    Enooku, Kenichiro
    Nakagawa, Hayato
    Asaoka, Yoshinari
    Shiina, Shuichiro
    Koike, Kazuhiko
    HEPATOLOGY, 2017, 66 : 760A - 761A
  • [6] Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C
    Tse, Chung Sang
    Yang, Ju Dong
    Mousa, Omar Y.
    Nelson, Kevin M.
    Pungpapong, Surakit
    Keaveny, Andrew
    Aqel, Bashar A.
    Vargas, Hugo
    Dickson, Rolland C.
    Watt, Kymberly
    Gores, Gregory J.
    Roberts, Lewis R.
    Leise, Michael D.
    TRANSPLANTATION DIRECT, 2021, 7 (01): : E635
  • [7] The Impact of Direct-acting Antiviral Therapy for Hepatitis C on Hepatocellular Carcinoma Risk
    Feng Su
    George N. Ioannou
    Current Hepatology Reports, 2018, 17 (4) : 377 - 384
  • [8] Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients
    Magdy Fouad
    Mohamed El Kassas
    Elham Ahmed
    Reem El Sheemy
    World Journal of Hepatology, 2021, 13 (11) : 1743 - 1752
  • [9] Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients
    Fouad, Magdy
    El Kassas, Mohamed
    Ahmed, Elham
    El Sheemy, Reem
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (11) : 1743 - 1752
  • [10] Predictive Factors for Hepatocellular Carcinoma Occurrence or Recurrence after Direct-Acting Antiviral Agents in Patients with Chronic Hepatitis C
    Yoshimasu, Yu
    Furuichi, Yoshihiro
    Kasai, Yoshitaka
    Takeuchi, Hirohito
    Sugimoto, Katsutoshi
    Nakamura, Ikuo
    Itoi, Takao
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2019, 28 (01) : 63 - 71
12345